UPLOAD Filing
Medicus Pharma Ltd.
Date: April 30, 2025 · CIK: 0001997296 · Accession: 0000000000-25-004582
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Medicus Pharma Ltd. Draft Registration Statement on Form S-1 Submitted April 25, 2025 CIK No. 0001997296 Dear Raza Bokhari:
April 30, 2025
Raza Bokhari Chief Executive Officer Medicus Pharma Ltd. 300 Conshohocken State Road, Suite 200 Conshohocken, PA 19428
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Christopher J. Cummings
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 30, 2025 Raza Bokhari Chief Executive Officer Medicus Pharma Ltd. 300 Conshohocken State Road, Suite 200 Conshohocken, PA 19428 Re: Medicus Pharma Ltd. Draft Registration Statement on Form S-1 Submitted April 25, 2025 CIK No. 0001997296 Dear Raza Bokhari: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Christopher J. Cummings </TEXT> </DOCUMENT>